Correlation of emmprin expression in vascular endothelial cells with blood-brain-barrier function: a study using magnetic resonance imaging enhanced by Gd-DTPA and immunohistochemistry in brain tumors.
In a previous study, we demonstrated that the expression levels in tumor cells of emmprin (CD147) correlated with the grade of astrocytic tumors. Also, we found that emmprin was expressed in vascular endothelial cells of the non-neoplastic brain and hypothesized that emmprin expression could be associated with normal blood-brain-barrier (BBB) function of vascular endothelial cells. In this study, this possibility was examined in non-neoplastic brain, glioma and metastatic carcinoma tissues by comparing emmprin immunohistochemistry with gadolinium diethylenetriaminepentaacetic acid (Gd-DTPA) enhancement of magnetic resonance imaging (MRI), which is a clinical indicator of the BBB function. This study included 10 cases of non-neoplastic brain tissues, 7 of metastatic carcinoma, 7 of diffuse astrocytoma, 4 of anaplastic astrocytoma and 13 of glioblastoma multiforme. In all the cases, MRI with administration of Gd-DTPA was performed. The lesions were resected using the microdissection method with the help of ultrasonography and a neuronavigator. The tissues from Gd-DTPA-enhanced or non-enhanced areas were processed into frozen sections and subjected to immunohistochemistry with anti-emmprin antibody. The expression of emmprin in brain vascular endothelial cells inversely correlated with Gd-DTPA-enhancement of MRI: emmprin was positive in tissues not enhanced by Gd-DTPA and was negative in DTPA-enhanced tissues. Since BBB function presumably remains unimpaired in regions in which MR images are not Gd-DTPA-enhanced, emmprin expression appears to be associated with unimpaired BBB function. This is the first report to demonstrate a possible correlation between emmprin expression and BBB function in humans.
Sameshima
Tetsuro
T
Department of Neurosurgery, Miyazaki Medical College, Miyazaki, Japan.
Nabeshima
Kazuki
K
Toole
Bryan P
BP
Inoue
Teruhiko
T
Yokogami
Kiyotaka
K
Nakano
Shinichi
S
Ohi
Takekazu
T
Wakisaka
Shinichiro
S
D000328:Adult; D000368:Aged; D015703:Antigens, CD; D000951:Antigens, Neoplasm / Q000378:metabolism*; D001254:Astrocytoma / Q000098:blood supply / Q000473:pathology / Q000601:surgery; D051926:Basigin; D014408:Biomarkers, Tumor / Q000378:metabolism; D001812:Blood-Brain Barrier / Q000502:physiology*; D001932:Brain Neoplasms / Q000098:blood supply* / Q000556:secondary / Q000601:surgery; D003287:Contrast Media; D004730:Endothelium, Vascular / Q000378:metabolism*; D005260:Female; D019786:Gadolinium DTPA; D006801:Humans; D007124:Immunoenzyme Techniques; D008279:Magnetic Resonance Imaging; D008297:Male; D008562:Membrane Glycoproteins / Q000378:metabolism*; D008875:Middle Aged
D015703:Antigens, CD; D000951:Antigens, Neoplasm; C497886:BSG protein, human; D014408:Biomarkers, Tumor; D003287:Contrast Media; D008562:Membrane Glycoproteins; D051926:Basigin; D019786:Gadolinium DTPA